World Health Organization, Kaduna, Nigeria.
International Faculty Coordinator, Euclid University, Banjul, The Gambia.
PLoS One. 2024 May 16;19(5):e0288567. doi: 10.1371/journal.pone.0288567. eCollection 2024.
The novel SARS-CoV-2 virus that causes Coronavirus disease (COVID-19) has redefined global health and response to Acute Respiratory Infection (ARI). The outbreak of a cluster of influenza-like illnesses in Wuhan, China, has morphed into a pandemic in the last quarter of 2019, stretching from South East Asia to Europe, The Americas, Africa, and the Australian subcontinent. We evaluated the prevalence of depression among outpatients diagnosed with ARI.
We utilized a cross-sectional, observational design and investigated the prevalence of symptoms of depression among outpatients with ARI and described the characteristics of outpatients with ARI in Kaduna State.
The prevalence of symptoms of depression was 19.6% for respondents with symptoms of ARI and 14.4% for those without symptoms of ARI. On no risk of depression, we had a higher proportion of the respondents without symptoms of ARI (86%) than those with symptoms of depression (80%) (M = 318.4, SD = 29.62 case, and M = 344.0, SD = 14.2 control, r = 0.88, CI = 13.5 to 6.5, P = 0.000952). Likewise, in the category with mild risk of depression, respondents without symptoms of ARI were fewer (10%) than those with symptoms of depression (15%) (M = 58.4, SD = 26.0 case, and M = 42.1, SD = 12.7 control, r = 0.86, CI = 11.8 to 5.8, P = 0.0136. There was no significant difference between respondents with symptoms of ARI and without symptoms of ARI in the categories of moderate (M = 13.6, SD = 5.1 case, and M = 11.6, SD = 4.6 control, r = 0.87, CI = 2.3 to 2.1, P = 0.178) and high (M = 5.6, SD = 2.5 case, and M = 4.4, SD = 3.2 control, r = 0.61, CI = 1.2 to 1.5, P = 0.174) risk of depression.
Symptoms of depression were commoner among respondents who presented with symptoms of Acute Respiratory Infection (ARI) at the Outpatient Department (OPD). However, further explanatory research is needed to establish causality.
导致冠状病毒病(COVID-19)的新型 SARS-CoV-2 病毒重新定义了全球健康和对急性呼吸道感染(ARI)的应对。在中国武汉市爆发的一系列流感样疾病已在 2019 年最后一个季度演变成大流行,从东南亚蔓延到欧洲、美洲、非洲和澳大利亚次大陆。我们评估了门诊诊断为 ARI 的患者中抑郁的患病率。
我们采用了横断面观察设计,调查了门诊 ARI 患者中抑郁症状的患病率,并描述了卡杜纳州门诊 ARI 患者的特征。
有 ARI 症状的患者中抑郁症状的患病率为 19.6%,无症状的患者为 14.4%。在无抑郁风险的情况下,我们有更高比例的无 ARI 症状的患者(86%)比有抑郁症状的患者(80%)(M=318.4,SD=29.62 例,M=344.0,SD=14.2 例)。同样,在轻度抑郁风险类别中,无 ARI 症状的患者(10%)少于有 ARI 症状的患者(15%)(M=58.4,SD=26.0 例,M=42.1,SD=12.7 例)。控制,r=0.88,CI=13.5 至 6.5,P=0.000952)。在中度(M=13.6,SD=5.1 例,M=11.6,SD=4.6 例)和高度(M=5.6,SD=2.5 例,M=4.4,SD=3.2 例)风险类别中,有 ARI 症状和无 ARI 症状的患者之间没有显著差异。控制,r=0.87,CI=2.3 至 2.1,P=0.178)和高(M=5.6,SD=2.5 例,M=4.4,SD=3.2 例)风险的抑郁。
在门诊(OPD)出现急性呼吸道感染(ARI)症状的患者中,抑郁症状更为常见。然而,需要进一步的解释性研究来确定因果关系。